EV/EBITDA
-7.73
-0.39-5.31%
6 min ago
Summary
- As of March 12, 2025, TVTX EV/EBITDA is -7.73, with a fall of -0.39 (-5.31%) during the most recent trading day.
- Over the past year, TVTX EV/EBITDA has dropped by -4.82 (-165.64%).
- TVTX EV/EBITDA is now -104.26% below its all-time high of 181.49.
Performance
TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TVTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -5.3% | +5.3% | +6.4% |
| 1 m1 month | +13.6% | -13.7% | -17.2% |
| 3 m3 months | -8.3% | +8.3% | +8.1% |
| 6 m6 months | -91.3% | +54.0% | +53.1% |
| ytdytd | -10.1% | +10.1% | +10.7% |
| 1 y1 year | -165.6% | +116.8% | +144.2% |
| 5 y5 years | -16.9% | +189.8% | +46.8% |
TVTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.1% | -9.42 | +17.9% | |
| 3 m | 3-month | -6.81 | -13.5% | -9.42 | +17.9% |
| 6 m | 6-month | -4.02 | -92.3% | -9.42 | +17.9% |
| 1 y | 1-year | -2.11 | -266.4% | -9.42 | +17.9% |
| 3 y | 3-year | -2.05 | -277.1% | -13.17 | +41.3% |
| 5 y | 5-year | -2.05 | -277.1% | -26.18 | +70.5% |
| alltime | all time | 181.49 | -104.3% | -5339 | +99.9% |
Travere Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.73(+10.1%) |
| 2024 | -7.02(+123.6%) |
| 2023 | -3.14(-60.4%) |
| 2022 | -7.93(-48.2%) |
| 2021 | -15.32(+40.4%) |
| 2020 | -10.91(+55.0%) |
| 2019 | -7.04(-50.8%) |
| Date | Value |
|---|---|
| 2018 | -14.31(-29.9%) |
| 2017 | -20.40(+3.9%) |
| 2016 | -19.64(-450.7%) |
| 2015 | 5.60(-130.3%) |
| 2014 | -18.48(+141.3%) |
| 2013 | -7.66(-99.7%) |
| 2012 | -2308.72 |
FAQ
- What is Travere Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Travere Therapeutics?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics EV/EBITDA year-on-year change?
What is Travere Therapeutics EV/EBITDA?
The current EV/EBITDA of TVTX is -7.73
What is the all time high EV/EBITDA for Travere Therapeutics?
Travere Therapeutics all-time high EV/EBITDA is 181.49
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics EV/EBITDA has changed by -0.71 (-10.11%) since the beginning of the year
What is Travere Therapeutics EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -4.82 (-165.64%)